These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7151085)

  • 1. Pharmacokinetics and metabolism of tiapamil.
    Wendt G
    Cardiology; 1982; 69 Suppl():68-78. PubMed ID: 7151085
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis.
    Hinderling PH; Eckert M; Gasic S; Eichler HG; Pötzi R; Heizmann P
    Eur J Clin Pharmacol; 1986; 31(4):397-404. PubMed ID: 3816918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiapamil, Ro 11-1781, a Ca++ antagonist. An improved synthesis, physiochemical properties, preparation of a deuterated derivative.
    Ramuz H
    Cardiology; 1982; 69 Suppl():26-30. PubMed ID: 7151082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion of tiapamil in breast milk.
    Hartmann D; Lunell NO; Friedrich G; Rane A
    Br J Clin Pharmacol; 1988 Aug; 26(2):183-6. PubMed ID: 3207555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of tiapamil, a calcium antagonist. Double-blind placebo crossover study.
    Chu D; De Gori D
    Cardiology; 1982; 69 Suppl():99-104. PubMed ID: 6758935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of tiapamil and of its two main metabolites in plasma and in urine by high-performance liquid chromatography.
    Heizmann P; Wendt G; Von Alten R; Zinapold K; Buser C
    J Chromatogr; 1984 Sep; 310(1):119-27. PubMed ID: 6501509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cardiac arrhythmias with tiapamil.
    Brisse B; Bender F; Bramann H; Kuhs H; Schwippe G
    Cardiology; 1982; 69 Suppl():144-8. PubMed ID: 7151076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term tiapamil treatment of patients with angina pectoris.
    Salorinne Y; Himberg JJ; Eskelinen E
    Clin Cardiol; 1983 Apr; 6(4):171-5. PubMed ID: 6404577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and dynamics of calcium entry antagonists in systemic hypertension.
    McAllister RG; Schloemer GL; Hamann SR
    Am J Cardiol; 1986 Feb; 57(7):16D-21D. PubMed ID: 3513512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
    Kim HJ; Choi JS
    Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction.
    Clozel JP
    Cardiology; 1988; 75(3):161-9. PubMed ID: 3416326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculography.
    Eckert M; Pozenel H; Pillat B
    J Clin Pharmacol; 1984 Apr; 24(4):165-73. PubMed ID: 6725618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
    Menzel T; Kirchner P
    Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo measurement of [11C]verapamil kinetics in human tissues.
    Hendrikse NH; de Vries EG; Franssen EJ; Vaalburg W; van der Graaf WT
    Eur J Clin Pharmacol; 2001; 56(11):827-9. PubMed ID: 11294373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative inotropic effects of tiapamil (Ro11-1781) and verapamil in rabbit myocardium.
    Harada S; Sada H; Kojima M; Ban T
    Eur J Pharmacol; 1982 Feb; 78(1):7-14. PubMed ID: 7075665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiapamil--a new calcium antagonist.
    Opie LH; Muller CA; Thandroyen FT; Lloyd EA; Mabin T; Commerford PJ; Eichler HG
    S Afr Med J; 1985 Jun; 67(22):881-3. PubMed ID: 3890216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of calcium-entry blockers.
    McAllister RG; Hamann SR; Blouin RA
    Am J Cardiol; 1985 Jan; 55(3):30B-40B. PubMed ID: 3881917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of verapamil, tiapamil, diltiazem and nifedipine on systemic and splanchnic hemodynamics in man.
    Gasic S; Eichler HG; Korn A
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):498-503. PubMed ID: 3679621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effect of intravenous tiapamil on methylergometrine-induced coronary artery spasm in patients with variant angina: randomized double-blind trial.
    Danchin N; Clozel JP; Khalife K; Elkik F; Boulay F; Neimann JL; Cherrier F
    Am Heart J; 1985 Apr; 109(4):764-8. PubMed ID: 3885699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.